Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| LUTEINIZING HORMONE, BETA | LUTEINIZING HORMONE, BETA. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BETA-HLH;BETA-LH, HUMAN PITUITARY;BETA-LH, PORCINE PITUITARY;BETA-LH, SHEEP PITUITARY;LUTEINIZING HORMONE, BETA;LUTEINIZING HORMONE, BETA-, HUMAN PITUITARY;LUTEINIZING HORMONE, BETA-, PORCINE PITUITARY;LUTEINIZING HORMONE, BETA-, SHEEP PITUITARY. Product Category: Heterocyclic Organic Compound. Appearance: lyophilized powder. CAS No. 53664-53-2. Product ID: ACM53664532. Alfa Chemistry ISO 9001:2015 Certified. Categories: Luteinizing hormone beta polypeptide. |  |
| Luteinizing hormone (human) | Luteinizing hormone (human), a heterodimeric glycoprotein hormone produced by the pituitary gland (LH), plays key roles in human reproduction [1]. Uses: Scientific research. Group: Peptides. CAS No. 39341-83-8. Pack Sizes: 10 μg; 50 μg. Product ID: HY-P2293. |  |
| Luteinizing hormone releasingfactor | Luteinizing hormone releasingfactor. Uses: Designed for use in research and industrial production. Additional or Alternative Names: LEUTINIZING HORMONE RELEASING HORMONE;LHRH (LAMPREY III);LH-RH ACETATE;LHRH;LHRH, HUMAN;LH-RH (HUMAN) PORCINE, RAT;LH-RH LUTEINIZING HORMONE-RELEASING HORMONE;LHRH (SEA BREAM). Product Category: Heterocyclic Organic Compound. CAS No. 9034-40-6. Molecular formula: C55H75N17O13. Mole weight: 1182.29. Product ID: ACM9034406. Alfa Chemistry ISO 9001:2015 Certified. | |
| Luteinizing Hormone-Releasing Hormone (LH-RH) | Luteinizing hormone releasing hormone (LH-RH) is a reproductive hormone. Synonyms: Salmon-gnrh; Gnrh, salmon-; Salmon-LHRH; LHRH (salmon). Grade: ≥95%. CAS No. 86073-88-3. Molecular formula: C60H73N15O13. Mole weight: 1212.3. |  |
| 6-D-Leucine-1-8-Luteinizing hormone-releasing factor (swine) | 6-D-Leucine-1-8-Luteinizing hormone-releasing factor (swine). Synonyms: Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-Seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginine; LHRH (1-8); 1-8-Luteinizing hormone-releasing factor (swine), 6-D-leucine-; Luteinizing hormone-releasing factor (pig), 6-D-leucine-9-de-L-proline-10-deglycinamide-; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginine. Grade: ≥95% by HPLC. CAS No. 112642-14-5. Molecular formula: C52H72N14O12. Mole weight: 1085.23. | |
| Luteinizinghormone-releasing factor(swine),5-(3,5-diiodo-L-tyrosine)-(9ci) | Luteinizinghormone-releasing factor(swine),5-(3,5-diiodo-L-tyrosine)-(9ci). Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYROGLU-HIS-TRP-SER-3,5-DIIODO-TYR-GLY-LEU-ARG-PRO-GLY-NH2;PYR-HIS-TRP-SER-3,5-DIIODO-TYR-GLY-LEU-ARG-PRO-GLY-NH2;(3,5-DIIODO-TYR5)-GONADOTROPIN-RELEASING HORMONE;(3,5-DIIODO-TYR5)-LHRH;(3,5-DIIODO-TYR5)-LUTEINIZING HORMONE-RELEASING FACTOR;(3,5-DIIODO-T. Product Category: Heterocyclic Organic Compound. CAS No. 73644-49-2. Molecular formula: C55H73I2N17O13. Mole weight: 1434.08. Purity: 0.96. IUPACName: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxy-3,5-diiodophenyl)-1. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC(=C(C(=C2)I)O)I)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6. Product ID: ACM73644492. Alfa Chemistry ISO 9001:2015 Certified. | |
| Luteinizinghormone-releasing factor(swine),6-L-tryptophan- | Luteinizinghormone-releasing factor(swine),6-L-tryptophan-. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (TRP6)-GONADOTROPIN-RELEASING HORMONE;(TRP6)-LHRH;(TRP6)-LUTEINIZING HORMONE-RELEASING FACTOR;(TRP6)-LUTEINIZING HORMONE-RELEASING HORMONE;(TRP6)-TRIPTORELIN;PYR-HIS-TRP-SER-TYR-TRP-LEU-ARG-PRO-GLY-NH2. Product Category: Heterocyclic Organic Compound. CAS No. 156126-74-8. Molecular formula: C64H82N18O13. Mole weight: 1311.45. Purity: 0.96. IUPACName: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8. Product ID: ACM156126748. Alfa Chemistry ISO 9001:2015 Certified. | |
| 2-Hydroxysaclofen | 2-Hydroxysaclofen is a potent γ-amino-butyric-acid-B (GABA B ) receptor antagonist. 2-Hydroxysaclofen can abolish nicotine-induced hypolocomotor effects and increases the antinociceptive effects. 2-Hydroxysaclofen can stimulate luteinizing hormone (LH) secretion in female rats [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 117354-64-0. Pack Sizes: 1 mg. Product ID: HY-100812. | |
| 4-D-Ser-goserelin | 4-D-Ser-goserelin is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-D-Ser(Ac)-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNHCONH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-O-acetyl-D-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N'-carbamoyl-L-prolinehydrazide; 4-(acetyl-D-serine)goserelin. Molecular formula: C61H86N18O15. Mole weight: 1311.47. | |
| 4-(glycolyl-L-serine)goserelin | 4-(glycolyl-L-serine)goserelin is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-D-Ser(Glycolyl)-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNHCONH2; (6S,9S,12R,15S,18S)-18-((S)-2-((S)-3-(1H-imidazol-5-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazinecarbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-1-imino-9-isobutyl-8,11,14,17-tetraoxo-2,7,10,13,16-pentaazanonadecan-19-yl 2-hydroxyacetate. Molecular formula: C61H86N18O16. Mole weight: 1327.45. | |
| 4-(Lactyl-L-serine)goserelin | 4-(Lactyl-L-serine)goserelin is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-D-Ser(Lactyl)-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNHCONH2; (6S,9S,12R,15S,18S)-18-((S)-2-((S)-3-(1H-imidazol-5-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-1-amino-12-(tert-butoxymethyl)-6-((S)-2-(2-carbamoylhydrazinecarbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-1-imino-9-isobutyl-8,11,14,17-tetraoxo-2,7,10,13,16-pentaazanonadecan-19-yl 2-hydroxypropanoate. Molecular formula: C62H88N18O16. Mole weight: 1341.47. | |
| [5-Phenylalanine]-LH-RH Acetate Hydrate (1:x:x) | It is a gonadotropin-releasing hormone (GnRH) analog. Synonyms: [5-Phenylalanine]-luteinizing hormone releasing hormone, acetate (salt), hydrate (1:x:x); [Phe5]-LH-RH, acetate (salt), hydrate (1:x:x); Phe5-LH-releasing hormone, acetate (salt), hydrate (1:x:x); Luteinizing hormone-releasing factor (swine), 5-L-phenylalanine-, acetate (salt), hydrate; Luteinizing hormone-releasing factor (pig), 5-L-phenylalanine-, acetate (salt), hydrate (1:x:x). CAS No. 78308-49-3. Molecular formula: C55H75N17O12.xC2H4O2.xH2O. Mole weight: 1166.31 (free base). | |
| 6-(des-t-butyl-D-serine)-goserelin | 6-(des-t-butyl-D-serine)-goserelin is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-D-Ser-Tyr-D-Ser-Leu-Arg-Pro-NHNHCONH2; (S)-N-((6S,9S,12S,15S,18S,21S,24S)-21-((1H-indol-3-yl)methyl)-1-amino-6-((S)-2-(2-carbamoylhydrazinecarbonyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-12,18-bis(hydroxymethyl)-25-(1H-imidazol-5-yl)-1-imino-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacosan-24-yl)-5-oxopyrrolidine-2-carboxamide. Molecular formula: C55H76N18O14. Mole weight: 1213.33. | |
| 8-(N-Acetylamino-L-arginine)-goserelin | 8-(N-Acetylamino-L-arginine)-goserelin is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-D-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro(Ac)-NHNHCONH2; (S)-N-((9S,12S,15R,18S,21S,24S,27S)-24-((1H-indol-3-yl)methyl)-15-(tert-butoxymethyl)-9-((S)-2-(2-carbamoylhydrazinecarbonyl)pyrrolidine-1-carbonyl)-18-(4-hydroxybenzyl)-21-(hydroxymethyl)-28-(1H-imidazol-5-yl)-4-imino-12-isobutyl-2,11,14,17,20,23,26-heptaoxo-3,5,10,13,16,19,22,25-octaazaoctacosan-27-yl)-5-oxopyrrolidine-2-carboxamide. Molecular formula: C61H86N18O15. Mole weight: 1311.47. | |
| Abarelix | Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with prostate hypertrophy or prostate cancer, since testosterone is required to sustain prostate growth. Check for active clinical trials or closed clinical trials using this agent. Synonyms: Plenaxis, PPI-149; PPI 149; PPI149; R-3827; R 3827; R3827. Grade: 98%. CAS No. 183552-38-7. Molecular formula: C72H95ClN14O14. Mole weight: 1416.09. | |
| Alarelin | Alarelin is a synthetic analog of Gonadotropin-releasing hormone (GnRH) used primarily for its effects on the reproductive system. It acts as a GnRH agonist, initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Alarelin is used in the treatment of conditions such as endometriosis, uterine fibroids, and prostate cancer, as well as in assisted reproductive technologies. Synonyms: 1-9-Luteinizing hormone-releasing factor (swine), 6-D-alanine-9-(N-ethyl-L-prolinamide)-; Luteinizing hormone-releasing factor (pig), 6-D-alanine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-; AY 25205; Dalarelin; Dalareline; L 4513; LHRH-A2; LRH-A2; Luteinizing hormone-releasing hormone analog 2; Surfagon; TAP 127; Wy 18481; H-Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt; L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-L-proline ethylamide; (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH; Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt; LHRH-A; 6-D-Ala-10-D-gly-LHRH-ethylamide; L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-L-proline ethylamide. Grade: 95%. CAS No. 52435-06-0. Molecular formula: C56H78N16O12. Mole weight: 1167.32. | |
| Alarelin acetate | Alarelin, more commonly existed as Alarelin acetate, has been found to be a GnRH agonist that could delay the sexual maturation in rats. Synonyms: Luteinizing hormone-releasing factor (swine), 6-D-alanine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, acetate (salt) (1:x); Luteinizing hormone-releasing factor (pig), 6-D-alanine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, acetate (salt) (1:x); H-Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt.xC2H4O2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-L-proline ethylamide acetic acid (1:x); (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH acetate salt; Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt acetate salt. Grade: 98%. CAS No. 148029-26-9. Molecular formula: C56H78N16O12.xC2H4O2. Mole weight: 1167.32 (free base). | |
| Alarelin diacetate | Alarelin acetate is a synthetic Gonadotrophin-releasing hormone agonist. It is the acetate form of a hypothalamic peptide. It is a potent LH-RH agonist in rats and mice. It reversibly delays sexual maturation in rats, stimulates spawning activity in fish. It could inducte ovulation and is used to treat endmometriosis. It is responsible for the secretion of gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary glands. Uses: Alarelin acetate could inducte ovulation and is used to treat endmometriosis. it is responsible for the secretion of gonadotropins, luteinizing hormone (lh) and follicle-stimulating hormone (fsh), from the pituitary glands. Synonyms: 1-9-Luteinizing hormone-releasing factor (swine), 6-D-alanine-9-(N-ethyl-L-prolinamide)-, acetate (1:2); 1-9-Luteinizing hormone-releasing factor (swine), 6-D-alanine-9-(N-ethyl-L-prolinamide)-, diacetate (salt); Luteinizing hormone-releasing factor (pig), 6-D-alanine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, diacetate (salt); Alarelin acetate; H-Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt.2C2H4. Grade: >98%. CAS No. 79561-22-1. Molecular formula: C60H86N16O16. Mole weight: 1287.42. | |
| BAY 1214784 | BAY 1214784 is a potent, selective, and orally active antagonist of the human gonadotropin-releasing hormone receptor ( hGnRH-R ). BAY 1214784 is a spiroindoline derivative compound. BAY 1214784 effectively lowers plasma luteinizing hormone levels by up to 49%, at the same time being associated with low pharmacokinetic variability and good tolerability. BAY 1214784 has the potential for the research of uterine fibroids [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1631164-25-4. Pack Sizes: 5 mg. Product ID: HY-144863. | |
| [betaAla-D-Cit]-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-beta-Ala-DCit-Leu-Arg-Pro-DAla-NH2; [β-Ala-D-Cit]-Cetrorelix; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-β-Ala-D-Cit-Leu-Arg-Pro-D-Ala-NH2; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-beta-alanyl-D-citrullyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; betaAla-DCit-Cetrorelix; betaAla-D-Cit-Cetrorelix. Grade: ≥95%. Molecular formula: C73H97ClN18O15. Mole weight: 1502.14. | |
| [betaAla-Leu]-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-beta-Ala-Leu-Arg-Pro-DAla-NH2; [β-Ala-Leu]-Cetrorelix; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-β-Ala-Leu-Arg-Pro-D-Ala-NH2; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-D-citrullyl-beta-alanyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; betaAla-Leu-Cetrorelix. Grade: ≥95%. Molecular formula: C73H97ClN18O15. Mole weight: 1502.14. | |
| Buserelin Acetate | Gondadotropin-releasing hormone agonist, used to treat hormone-responsive cancers such as prostate and breast cancer. Synthetic nonapeptide agonist analog of LH-RH. Antineolpastic (hormonal). Group: Biochemicals. Alternative Names: 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor Monoacetate; Estomal; Suprafact; Suprecur; Supremon. Grades: Highly Purified. CAS No. 68630-75-1. Pack Sizes: 10mg. Molecular Formula: C??H??N??O??, Molecular Weight: 1299.48. US Biological Life Sciences. |  Worldwide |
| Cetrorelix | Cetrorelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist. Cetrorelix inhibits the endogenous luteinizing hormone surge during ovarian stimulation. Cetrorelix reduces cyclophosphamide induced ovarian follicular destruction in mice [1] [2]. Uses: Scientific research. Group: Peptides. Alternative Names: SB-75. CAS No. 120287-85-6. Pack Sizes: 1 mg. Product ID: HY-P0009. | |
| Cetrorelix Acetate | Cetrorelix Acetate is the acetate salt of cetrorelix, which is a potent and synthetic peptide antagonist of gonadotropin-releasing hormone (GnRH) receptor antagonist with IC50 value of 1.21 nM. It binds to radioligand murine LTK- cells with Kd value of 0.2 nM. It inhibits the activation of hGnRHR and a downstream luciferase reporter gene in murine LTK- cells by the GnRHR agonist [D-Trp6]GnRH. It suppresses production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. It prevents ovulation during in vitro fertilization. It causes prepubertal reduction in bone density, bone strength and bone modeling. It was used as a therapeutic agent for the treatment of blood cancers such as multiple myeloma (MM). It is also used to treat hormone-sensitive cancers of the breast and prostate. It also has antidepressant and anxiolytic activity in vivo. Uses: Fertility agents, female. Synonyms: D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-, acetate (1:x); D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-, acetate (salt); Cetrotid; C. Grade: >98%. CAS No. 145672-81-7. Molecular formula: C70H92ClN17O14.xC2H4O2. Mole weight: 1431.06 (free base) | |
| DCOIT | DCOIT is a representative isothiazolinone that stimulates the gonadotropin-releasing hormone receptor ( GnRHR )-mediated synthesis of follicle-stimulating hormone and luteinizing hormone in the brain. DCOIT interferes with G protein-coupled receptors, MAPK and Ca 2+ signaling cascades [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Kathon 930. CAS No. 64359-81-5. Pack Sizes: 10 mM * 1 mL; 5 g. Product ID: HY-W041308. | |
| Degarelix | Degarelix acetate is a reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist. Degarelix reduces the secretion of luteinizing hormone (LH) and testosterone via blocking GnRHR. Degarelix can be used for the treatment of prostate cancer. Synonyms: Degarelix; Firmagon; FE-200486; FE 200486; FE200486; ASP-3550; ASP 3550; ASP3550; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Phe(4-S-dihydroorotamido)-D-Phe(4-ureido)-Leu-Lys(iPr)-Pro-D-Ala-NH2. Grade: >98%. CAS No. 214766-78-6. Molecular formula: C82H103ClN18O16. Mole weight: 1632.286. | |
| Degarelix acetate hydrate | Degarelix acetate is a synthetic peptide that acts as a gonadotrophin-releasing hormone (GnRH) antagonist. Degarelix targets GnRH receptors in the pituitary gland, resulting in reduction of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and suppression of testosterone. Synonyms: FE-200486; FE 200486; FE200486; ASP-3550; ASP 3550; ASP3550. CAS No. 934246-14-7. Molecular formula: C84H109ClN18O19. Mole weight: 1710.32. | |
| [Des-Ac-D-2Nal]-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: D4Cpa-D3Pal-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH2; Des-Ac-D2NalCetrorelix; D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2; 4-Chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-D-citrullyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; Des-Ac-D2Nal-Cetrorelix; [Des-Ac-D-2Nal]1-Cetrorelix. Grade: ≥95%. Molecular formula: C55H79ClN16O12. Mole weight: 1191.79. | |
| [Des-D-Ala-NH2]-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-Leu-Arg-Pro; Des-DAla-NH2-Cetrorelix; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-OH; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-D-citrullyl-L-leucyl-L-arginyl-L-proline; [Des-D-Ala-NH2]10-Cetrorelix; Des-D-Ala-Cetrorelix; 1-9 Acid Cetrorelix; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-Leu-Arg-Proline. Grade: ≥95%. CAS No. 2901757-75-1. Molecular formula: C67H86ClN15O14. Mole weight: 1360.97. | |
| (Des-gly10,d-ala6,pro-nhet9)-lhrh ii(chicken) | (Des-gly10,d-ala6,pro-nhet9)-lhrh ii(chicken). Uses: Designed for use in research and industrial production. Additional or Alternative Names: (DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING FACTOR (CHICKEN);(DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING HORMONE (CHICKEN);(DES-GLY10,D-ALA6,PRO-NHET9)-LHRH;(DES-GLY10,D-ALA6,PRO-NHET9)-GONADOTROPIN-RELEASING HORMONE (CHICKE. Product Category: Heterocyclic Organic Compound. CAS No. 319432-42-3. Molecular formula: C61H72N16O12. Mole weight: 1139.26. Product ID: ACM319432423. Alfa Chemistry ISO 9001:2015 Certified. | |
| (Des-Gly10,D-Ser(tBu)6,Pro-NHNH29)-LHRH | (Des-Gly10,D-Ser(tBu)6,Pro-NHNH29)-LHRH is the impurity E of the Goserelin. Synonyms: Decarbamoylgoserelin; H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-prolinehydrazide; 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (swine), hydrazide. Grade: 95%. CAS No. 147688-42-4. Molecular formula: C58H83N17O13. Mole weight: 1226.39. | |
| Deslorelin acetate | Deslorelin acetate. Group: Biochemicals. Alternative Names: 6-D-Tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (swine) monoacetate; Bachem 9022 acetate; D-Trp LHRH-PEA acetate. Grades: Highly Purified. CAS No. 82318-06-7. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C66H87N17O14. US Biological Life Sciences. | Worldwide |
| (D-His2)-Leuprolide Trifluoroacetic Acid Salt | (D-His2)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 2-D-Histidine-6-D-leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (swine) 2,2,2-Trifluoroacetate; 2: PN: WO2009040073 PAGE: 98 claimed protein. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| Di-Arg-Alarelin | Di-Arg-Alarelin is a modified form of Alarelin. Alarelin is a synthetic analog of Gonadotropin-releasing hormone (GnRH) used primarily for its effects on the reproductive system. It acts as a GnRH agonist, initially stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Alarelin is used in the treatment of conditions such as endometriosis, uterine fibroids, and prostate cancer, as well as in assisted reproductive technologies. Synonyms: Glp-His-Trp-Ser-Tyr-DAla-Leu-Arg-Arg-Pro-NHEt; H-Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Arg-Pro-NHEt; Glp-HWSY-DAla-LRRP-NHEt; L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-L-arginyl-L-proline ethylamide; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-alanyl-L-leucyl-L-arginyl-L-arginyl-N-ethyl-L-Prolinamide; (+Arg8)-Alarelin; Glp-HWSYaLRRP-NHEt. Grade: ≥95%. Molecular formula: C62H90N20O13. Mole weight: 1323.53. | |
| Di-Ser4-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH2; [Di-Ser]4-Cetrorelix; [Di-Ser4]-Cetrorelix; Di-Ser(4)-Cetrorelix; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-seryl-L-tyrosyl-D-citrullyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide. Grade: ≥95%. Molecular formula: C73H97ClN18O16. Mole weight: 1518.14. | |
| D-Leu7-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-DLeu-Arg-Pro-DAla-NH2; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-D-Leu-Arg-Pro-D-Ala-NH2; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-D-citrullyl-D-leucyl-L-arginyl-L-prolyl-D-alaninamide; [D-Leu]7-Cetrorelix; [D-Leu7]-Cetrorelix; D-Leu(7)-Cetrorelix. Grade: ≥95%. CAS No. 3031679-81-6. Molecular formula: C70H92ClN17O14. Mole weight: 1431.06. | |
| (D-Ser4)-Leuprolide Trifluoroacetic Acid Salt | (D-Ser4)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 4-D-serine-6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing Factor (pig) 2,2,2-Trifluoroacetate. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| (D-Trp6)-LHRH (free acid) | An impurity of Triptorelin and a luteinizing hormone-releasing hormone (LHRH) agonist. Synonyms: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly; Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-10-glycine- (9CI). Grade: 98%. CAS No. 129418-54-8. Molecular formula: C64H81N17O14. Mole weight: 1312.43. | |
| (D-Trp6)-LHRH free acid | (D-Trp6)-LHRH free acid is a luteinizing hormone-releasing hormone ( LHRH ) agonist [1]. Uses: Scientific research. Group: Peptides. CAS No. 129418-54-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P4572. | |
| D-Tyr5-Cetrorelix | An impurity of Cetrorelix. Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist used primarily in reproductive medicine and oncology. It works by competitively binding to GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn prevents ovulation and reduces the production of sex steroids. Synonyms: Ac-D2Nal-D4Cpa-D3Pal-Ser-DTyr-DCit-Leu-Arg-Pro-DAla-NH2; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-D-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2; N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-D-tyrosyl-D-citrullyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; [D-Tyr]5-Cetrorelix; [D-Tyr5]-Cetrorelix; D-Tyr(5)-Cetrorelix. Grade: ≥95%. CAS No. 3031679-86-1. Molecular formula: C70H92ClN17O14. Mole weight: 1431.06. | |
| (D-Tyr5)-Leuprolide Trifluoroacetic Acid Salt | (D-Tyr5)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 5-D-Tyrosine-6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing Factor (swine) 2,2,2-Trifluoroacetate. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| Fertirelin | Fertirelin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYR-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;PYROGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO NHCH2CH3;PGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;FERTIRELIN;GLP-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;[DES-GLY10] LH-RH, ETHYL AMIDE;[DES-GLY10] LUTEINIZING HORMONE-RELEASI. Product Category: Heterocyclic Organic Compound. CAS No. 38234-21-8. Molecular formula: C55H76N16O12. Mole weight: 1153.29. Purity: >98%. Density: 1.49 g/cm³. Product ID: ACM38234218. Alfa Chemistry ISO 9001:2015 Certified. | |
| Fulvestrant | Fulvestrant is a selective estrogen receptor degrader (SERD) that downregulates and degrades estrogen receptor α (ERα).1,2 It binds to rat uterine ER with an IC50 value of 44.8nM and prevents uterine weight increases induced by estradiol in immature rats (ED50> = 0.06mg/kg per day) but has no effect on uterine weight alone.3 It also decreases uterine weight in adult rats without affecting the production of luteinizing and follicle-stimulating hormones and prolactin. Fulvestrant inhibits the growth of ER-positive MCF-7 human breast cancer cells but not ER-negative BT-20 cells when used at a concentration of 1ug/ml. It also prevents tumor growth in MCF-7 and Br10 breast cancer mouse xenograft models when used at a single dose of 5mg per animal. Fulvestrant is neuroprotective in vitro against neurotoxicity induced by glutamate- and amyloid- β (1-42) (A β42) in primary rat hippocampal cells.4 Formulations containing fulvestrant have been used in the treatment of estro Group: Biochemicals. Alternative Names: (7α,17 β ) -7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol; Faslodex; Fulvestrant; ICI 182780; ZD 182780; ZD 9238; ZM 182780. Grades: Highly Purified. CAS No. 129453-61-8. Pack Sizes: 50mg, 100mg. Molecular Formula: C??H??F?O?S, Molecular Weight: 606.77. US Biological Life Sciences. | Worldwide |
| Glycinamide ribonucleotide | Glycineamide ribonucleotide (or GAR) is an intermediate in de novo purine biosynthesis. It is formed from phosphoribosylamine by the enzyme phosphoribosylamine-glycine ligase. In the next step of purine biosynthesis the enzyme phosphoribosylglycinamide formyltransferase acts on GAR to form FGAR. GAR formation is stimulated by Luteinizing hormone (LH) and Chorionic gonadotropin (HCG) via activation of Glc-6-P-dehydrogenase. Synonyms: 5'-Phosphoribosylglycinamide; N1-(5-Phospho-D-ribosyl)glycinamide; [(2R,3S,4R,5R)-5-[(2-aminoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate; n-glycyl-5-o-phosphono-|A-d-ribofuranosylamine; 5'-phosphoribosylglycinamide; GAR; N1-(5-Phospho-D-ribosyl)glycinamide; N1-(5-phospho-beta-D-ribosyl)glycinamide. CAS No. 10074-18-7. Molecular formula: C7H15N2O8P. Mole weight: 286.18. | |
| Gly-Ser-Trp-Tyr-Arg | Gly-Ser-Trp-Tyr-Arg is a sequence of amino acids that can be found in the peptide gonadotropin-releasing hormone (GnRH). GnRH is a hormone that controls reproduction by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Synonyms: mut4-FITC. | |
| Gonadorelin acetate | Gonadorelin acetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Cystorelin, Lutrepulse, Fertiline, Lutrelef, Luprolite acetate, Gonadorelin acetate, CID11980076, LS-88221, Luteinizing hormone-releasing factor (pig), acetate (salt), Synthetic luteinizing hormone-releasing factor acetate, Luteinizing hormone-releasing factor (swine), acetate (salt), 34973-08-5, 66036-44-0. Product Category: Heterocyclic Organic Compound. CAS No. 66036-44-0. Molecular formula: C55H75N17O13. Mole weight: 1242.342060 [g/mol]. Purity: 0.96. IUPACName: acetic acid; (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl). Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O. Product ID: ACM66036440. Alfa Chemistry ISO 9001:2015 Certified. | |
| Goserelin Acetate | Goserelin Acetate. Group: Biochemicals. Alternative Names: 6-[O-(1,1-Dimethylethyl)-D-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2- (Aminocarbonyl) hydrazide Acetate; Fertilan;D-Ser(But)6Azgly10-gonadorelin. Grades: Highly Purified. CAS No. 145781-92-6. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C??H??N??O??; x C?H?O?, Molecular Weight: 1269.41. US Biological Life Sciences. | Worldwide |
| Goserelin Acetate | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsbuilding blocks. Alternative Names: 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (1:?),Goserelin Acetate, Fertilan, 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (salt) (9CI), Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-10-deglycinamide-, 2-(aminocarbonyl)hydrazide, acetate (salt). |  |
| Goserelin EP Impurity C | Goserelin EP Impurity C is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-D-Pro-NHNHCONH2; [9-D-proline]goserelin; (9-D-proline)goserelin. Molecular formula: C59H84N18O14. Mole weight: 1269.43. | |
| Goserelin EP Impurity D | Goserelin EP Impurity D is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-NHNHCONH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-N'-carbamoyl-L-argininehydrazide; des-9-L-proline-goserelin. Molecular formula: C54H77N17O13. Mole weight: 1172.32. | |
| Goserelin EP Impurity H | Goserelin EP Impurity H is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-D-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNHCONH2; [1-(5-oxo-D-proline)]goserelin. Molecular formula: C59H84N18O14. Mole weight: 1269.43. | |
| Goserelin EP Impurity I | Goserelin EP Impurity I is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Pro-Pro-NHNHCONH2; endo-8a,8b-di-L-proline-goserelin. Molecular formula: C69H98N20O16. Mole weight: 1463.67. | |
| Goserelin EP Impurity J | Goserelin EP Impurity J is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Pro-NHNHCONH2; endo-8a-L-proline-goserelin. Molecular formula: C64H91N19O15. Mole weight: 1366.55. | |
| Goserelin EP Impurity K | Goserelin EP Impurity K is an impurity of Goserelin, a luteinizing hormone-releasing hormone analog that mediates the release of gonadotropins. Goserelin can be used to treat prostate cancer and breast cancer. Synonyms: H-Pyr-His-Trp-Ser(Ac)-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNHCONH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-O-acetyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N'-carbamoyl-L-prolinehydrazide; [4-(O-acetyl-L-serine)]goserelin. Molecular formula: C61H86N18O15. Mole weight: 1311.47. | |
| H-Gly-Leu-Asp-Trp-Trp-Ser-Leu-OH | Gly-Leu-Asp-Trp-Trp-Ser-Leu is part of the sequence of the decapeptide gonadotropin-releasing hormone (GnRH). GnRH is a hormone that regulates reproduction by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Molecular formula: C43H57N9O11. Mole weight: 875.96. | |
| H-Ser-tyr-gly-leu-arg-pro-gly-nh2 | H-Ser-tyr-gly-leu-arg-pro-gly-nh2. Uses: Designed for use in research and industrial production. Additional or Alternative Names: LH-RH Fragment 4-10, Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, Luteinizing hormone releasing hormone Fragment 4-10, AC1N71DH, SureCN11884805, L5387_SIGMA, 1-[2-[[2-[[2-[[2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide, 51776-33-1. Product Category: Heterocyclic Organic Compound. CAS No. 51776-33-1. Molecular formula: C33H53N11O9. Mole weight: 747.84. Purity: 0.96. IUPACName: 1-[2-[[2-[[2-[[2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)N. Product ID: ACM51776331. Alfa Chemistry ISO 9001:2015 Certified. | |
| Leuprolide Acetate | Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal). Group: Biochemicals. Alternative Names: 6-D-Leucine-9- (N-ethyl-L-prolinamide ) -10-deglycinamide luteinizing Hormone-Releasing Factor Acetate(Pig); A 43818; Abbott 43818; Leuprorelin Acetate; Lupron; Procren Depot; Procrin; Prostap; TAP 144; TAP 144SR. Grades: Highly Purified. CAS No. 74381-53-6. Pack Sizes: 10mg, 25mg. Molecular Formula: C??H??N??O??, Molecular Weight: 1269.45. US Biological Life Sciences. | Worldwide |
| Leuprolide Acetate EP Impurity E | Leuprolide Acetate EP Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Leuprolide Acetate EP Impurity E, 1-9-Luteinizing hormone-releasing factor (swine), 3-D-tryptophan-6-D-leucine-9-(N-ethyl-L-prolinamide)-,L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-D-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-. CAS No. 1926163-23-6. IUPAC Name: (2S)-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide. Molecular formula: C59H84N16O12. Mole weight: 1209.40. Catalog: APS1926163236. SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6. Format: Neat. | |
| Leuprolide Acetate EP Impurity H | Leuprolide Acetate EP Impurity H. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Leuprolide Acetate EP Impurity H,Luteinizing hormone-releasing factor (swine), 6-D-leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide- (9CI), Luteinizing hormone-releasing factor (pig), 6-D-leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-. CAS No. 112710-58-4. IUPAC Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide. Molecular formula: C59H84N16O12. Mole weight: 1209.40. Catalog: APS112710584. SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6. Format: Neat. | |
| LGnRH-III, lamprey acetate | LGnRH-III, lamprey acetate, a GnRH isoform isolated from the sea lamprey, is a weak GnRH receptor agonist with anti-tumor activity. It is an evolutionarily conserved member of the GnRH family and can stimulate the secretion of gonadotropins, luteinizing, and follicle-stimulating hormones. Synonyms: H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-histidyl-L-alpha-aspartyl-L-tryptophyl-L-lysyl-L-prolyl-glycinamide acetate. Grade: ≥95%. Molecular formula: C61H78N18O16. Mole weight: 1319.38. | |
| Lhrh(1-6)(free acid) | Lhrh(1-6)(free acid). Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYR-HIS-TRP-SER-TYR-GLY-OH TRIFLUOROACETATE SALT;LUTEINIZING HORMONE-RELEASING HORMONE (1-6) TRIFLUOROACETATE SALT;LUTEINIZING HORMONE-RELEASING FACTOR (1-6) TRIFLUOROACETATE SALT;GONADOTROPIN-RELEASING HORMONE (1-6) TRIFLUOROACETATE SALT;LHRH (1-6) TRIF. Product Category: Heterocyclic Organic Compound. CAS No. 103067-73-8. Molecular formula: C36H41N9O10. Mole weight: 873.79. Product ID: ACM103067738. Alfa Chemistry ISO 9001:2015 Certified. Categories: LHRH (1-6) (free acid). | |
| LHRH (chicken) | It is a luteinizing hormone-releasing hormone (LHRH) that stimulates the anterior pituitary to release gonadotropins, thereby regulating reproductive function. Synonyms: H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-glutaminyl-L-prolyl-glycinamide; [Gln8]-C517 (LH-RH), chicken; 8-Glutamine-LHRH; GNRH, Chicken I; 8-Gln-LHRH; LHRH-I; pGlu-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2. Grade: 95%. CAS No. 47922-48-5. Molecular formula: C54H71N15O14. Mole weight: 1154.23. | |
| LHRH (free acid) | LHRH (free acid), also known as Luteinizing Hormone-Releasing Hormone free acid, is a neuropeptide that plays a crucial role in regulating reproduction. This hormone is secreted by the hypothalamus and acts on the anterior pituitary gland to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are essential for reproductive functions. Synonyms: Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly; H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-OH; 10-Glycine-luteinizing hormone-releasing factor (swine); 10-Glycine-luteinizing hormone-releasing factor (pig); 10-Glycine-LH-RH; [Gly-OH10]-LHRH; LH-RH(OH); LHRH acid; PGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly; LHRH free acid; L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycine; XHWSYGLRPG. Grade: ≥95%. CAS No. 35263-73-1. Molecular formula: C55H74N16O14. Mole weight: 1183.27. | |
| LHRH free acid | LHRH (free acid), the luteinizing hormone-releasing hormone, is a neuropeptide hypothalamic. LHRH regulates reproduction. LHRH can be used for the research of cancer [1]. Uses: Scientific research. Group: Peptides. CAS No. 35263-73-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P4675. | |
| LHRH II | LHRH II, first found in chicken, is highly conserved in vertebrates. Synonyms: LH-RH II, chicken; Pyr-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2; LHRH, His(5)-Trp(7)-Tyr(8)-; Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-histidylglycyl-L-tryptophyl-L-tyrosyl-L-prolyl-; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-histidylglycyl-L-tryptophyl-L-tyrosyl-L-prolylglycinamide; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-histidyl-glycyl-L-tryptophyl-L-tyrosyl-L-prolyl-glycinamide; GNRH, Chicken II; pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2; 5-Histidyl-7-tryptophyl-8-tyrosine-LHRH; Luteinizing hormone-releasing factor II (chicken); cGnRH II. Grade: ≥95%. CAS No. 91097-16-4. Molecular formula: C60H69N17O13. Mole weight: 1236.32. | |
| Nafarelin | Nafarelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-2Nal-Leu-Arg-Pro-Gly-NH2. CAS No. 76932-56-4. Molecular formula: C66H83N17O13. Mole weight: 1322.45. | |
| Nafarelin acetate | Nafarelin acetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: NAFARELIN ACETATE;(6-D-(2-Naphthyl)alanine)lhrh acetate;(6-D-(2-Naphthyl)alanine)luteinizing hormone-releasing hormone acetate;Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-, monoacetate (salt);Luteinizing hormone-releasing. Product Category: Heterocyclic Organic Compound. CAS No. 78115-72-7. Molecular formula: C68H87N17O15. Mole weight: 1382.52. Product ID: ACM78115727. Alfa Chemistry ISO 9001:2015 Certified. | |
| Ozarelix | Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. Mechanistically, LHRH antagonists exert rapid inhibition of luteinizing hormone and follicle stimulating hormone with an accompanying rapid decrease in sex hormones and would therefore be expected to be effective in a variety of hormonally dependent disease states including ovarian cancer, prostate cancer, BPH, infertility, uterine myoma and endometriosis. BPH is a non-cancerous enlargement of the prostate that is caused by testosterone. Unlike LHRH agonists, ozarelix has the potential to reduce testosterone just enough to reduce both prostate size and symptoms without the severe side effects associated with a reduction in testosterone. Synonyms: D 63153; D-63 153; D-63153; D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-. CAS No. 295350-45-7. Molecular formula: C72H96ClN17O14. Mole weight: 1459.11. | |
| pyroglutamyl-peptidase II | Highly specific for thyrotropin releasing hormone (pyroglutamyl-histidyl-prolylamide). Will not cleave the pyroglutamyl-histidyl bond of luteinizing hormone releasing hormone. Found in serum and brain. Inhibited by metal chelators. In peptidase family M1 (membrane alanyl aminopeptidase family). Group: Enzymes. Synonyms: thyroliberinase; pyroglutamyl aminopeptidase II; thyrotropin-releasing factor pyroglutamate aminopeptidase; pyroglutamate aminopeptidase II; pyroglutamyl peptidase II; thyroliberin-hydrolyzing pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading peptidase; TRH aminopeptidase. Enzyme Commission Number: EC 3.4.19.6. CAS No. 60063-88-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4090; pyroglutamyl-peptidase II; EC 3.4.19.6; 60063-88-9; thyroliberinase; pyroglutamyl aminopeptidase II; thyrotropin-releasing factor pyroglutamate aminopeptidase; pyroglutamate aminopeptidase II; pyroglutamyl peptidase II; thyroliberin-hydrolyzing pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading peptidase; TRH aminopeptidase. Cat No: EXWM-4090. |  |
| Sufugolix | Sufugolix (TAK-013) is a highly potent and orally available luteinizing hormone-releasing hormone (LHRH) receptor antagonist with an IC50 of 0.1 nM. Uses: Scientific research. Group: Signaling pathways. Alternative Names: TAK-013. CAS No. 308831-61-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100209. | |
Our database is helping our users find suppliers everyday.
